| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $37K | -87.2% | -88.3% |
| Cost of Revenue | $17K | -92.0% | -92.9% |
| Gross Profit | $20K | -74.0% | -74.0% |
| R&D Expense | $4K | +33.3% | -33.3% |
| SG&A Expense | $961K | +3.7% | +6.4% |
| Operating Income | -$945K | -10.8% | -13.6% |
| Pre-tax Income | -$552K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8.5M | +51.1% | +73.6% |
| Accounts Receivable | $78K | -69.2% | +16.4% |
| Inventory | $0 | — | -100.0% |
| Current Assets | $14.9M | +5.4% | -14.0% |
| Total Assets | $29.1M | -1.6% | -6.4% |
| Current Liabilities | $1.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.3M | — | — |
| Capital Expenditures | $3K | — | — |
| Investing Cash Flow | $3.8M | — | — |
| Free Cash Flow | -$1.3M | — | — |
| -5.1% |
| -25.5% |
| Income Tax | $0 | — | — |
| Net Income | -$552K | -5.3% | -25.5% |
| EPS (Basic) | $0.00 | — | — |
| +0.0% |
| +8.6% |
| Total Liabilities | $1.4M | +0.0% | +8.6% |
| Stockholders' Equity | $27.7M | -1.7% | -7.1% |